Author(s): Naveen Pemmaraju, Kendra Sweet, Andrew Lane, Anthony Stein, et al. Abstract: S116 Session topic: 4. Acute myeloid leukemia – Clinical Background: SL-401 is a novel targeted therapy directed to the interleukin-3 receptor-α (CD123), a target expressed on blastic plasmacytoid dendritic cell neoplasm (BPDCN) and other malignancies. BPDCN is a highly aggressive...
Pro zobrazení tohoto obsahu je třeba být přihlášen.